EUVIMEDEUVIMED entdecken
Crossref

Mitochondrial NNT Promotes Diastolic Dysfunction in Cardiometabolic HFpEF

Mark E Pepin iD, Philipp J M Konrad iD, Sumra Nazir, Farhad Bazgir iD, Christoph Maack iD, Alexander Nickel, Joshua M Gorman iD, Mathias Hohl iD, Friederike Schreiter iD, Matthias Dewenter, Adriano de Britto Chaves Filho, Almut Schulze iD und 5 weitere

Circulation Research · 2025

DOI: 10.1161/circresaha.125.326154 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation Research, 2025. Verfasst von Mark E Pepin und 16 weiteren Autor:innen. Beteiligte Einrichtung: Medical Faculty Heidelberg, Institute of Experimental Cardiology (M.E.P., P.J.M.K., S.N., F.B., F.S., M.D., J.B.), Heidelberg University, Germany. Hauptthemen laut MEDLINE: Mitochondria, Heart, NADP Transhydrogenase, AB-Specific, Heart Failure, Stroke Volume. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Clinical management of heart failure with preserved ejection fraction (HFpEF) is hindered by a lack of disease-modifying therapies capable of altering its distinct pathophysiology. Despite the widespread implementation of a 2-hit model of cardiometabolic HFpEF to inform precision therapy, which utilizes HFD+L-NAME (ad libitum high-fat diet and 0.5% N[ω]-nitro-L-arginine methyl ester), we observe that C57BL6/J mice exhibit less cardiac diastolic dysfunction in response to HFD+L-NAME. METHODS: Genetic strain-specific single-nucleus transcriptomic analysis identified disease-relevant genes that enrich oxidative metabolic pathways within cardiomyocytes. Because C57BL/6J mice are known to harbor a loss-of-function mutation affecting the inner mitochondrial membrane protein Nnt (nicotinamide nucleotide transhydrogenase), we established an isogenic model of Nnt loss-of-function to determine whether intact NNT is necessary for the pathological cardiac manifestations of HFD+L-NAME. Twelve-week-old mice cross-bred to isolate wild-type ( Nnt +/+ ) or loss-of-function ( Nnt − / − ) Nnt in the C57BL/6N background were challenged with HFD+L-NAME for 9 weeks (N=6–10). RESULTS: Nnt +/+ mice exhibited impaired ventricular diastolic relaxation and pathological remodeling, as assessed via noninvasive echocardiographic quantification of early diastolic pulse-wave velocity (E) to mitral annular velocity (e′) ratio (E/e′) (42.8 versus 21.5, P =1.2×10 − 10 ), E/A (early-to-late mitral inflow velocity ratio) (2.3 versus 1.4, P =4.1×10 − 2 ), diastolic stiffness (0.09 versus 0.04 mm Hg/μL, P =5.1×10 − 3 ), and myocardial fibrosis ( P =2.3×10 − 2 ). Liquid chromatography and mass spectroscopy exposed a 40.0% reduction in NAD + ( P =8.4×10 − 3 ) and a 38.8% reduction in the ratio of reduced-to-oxidized glutathione (GSH: GSSG, P =2.6×10 − 2 ) among Nnt +/+ mice after HFD+L-NAME feeding. Using single-nucleus ligand-receptor analysis, we implicate Fgf1 (fibroblast growth factor 1) as a putative NNT-dependent mediator of cardiomyocyte-to-fibroblast signaling in myocardial fibrosis. CONCLUSIONS: Together, these findings underscore the pivotal role of mitochondrial dysfunction in HFpEF pathogenesis, implicating both NNT and Fgf1 as novel therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mitochondria, HeartNADP Transhydrogenase, AB-SpecificHeart FailureStroke VolumeVentricular Function, LeftAnimalsMice, Inbred C57BLMiceMaleDiet, High-FatDisease Models, AnimalNG-Nitroarginine Methyl EsterMyocytes, CardiacDiastoleMice, KnockoutMitochondrial Proteins

Stichwörter der Autor:innen

NG-nitroarginine methyl esterfibrosisgenetic therapyheart failureoxidative stress

Substanzen

Nnt protein, mouseNADP Transhydrogenase, AB-SpecificNG-Nitroarginine Methyl EsterMitochondrial Proteins

Autor:innen und Institutionen

  • Medical Faculty Heidelberg, Institute of Experimental Cardiology (M.E.P., P.J.M.K., S.N., F.B., F.S., M.D., J.B.), Heidelberg University, Germany.
  • Department of Internal Medicine VIII (M.E.P., P.J.M.K., S.N., F.B., F.S., M.D., J.B.), Heidelberg University Hospital, Germany.
  • German Center for Cardiovascular Research (DZHK) (M.E.P., P.J.M.K., S.N., F.B., F.S., M.D., N.F., J.B.).
  • Department of Genetics, Harvard Medical School, Boston, MA (M.E.P., J.M.G., C.E.S., J.G.S.).
  • Cardiovascular Disease Initiative, Broad Institute of Harvard and MIT, Boston, MA (M.E.P.).
  • Stanford Cardiovascular Institute, Stanford University School of Medicine, CA (M.E.P.).

ORCID-Profile: Mark E Pepin, Philipp J M Konrad, Farhad Bazgir, Christoph Maack, Joshua M Gorman, Mathias Hohl, Friederike Schreiter, Almut Schulze, Anja Karlstaedt, Norbert Frey, Christine E Seidman, Jonathan G Seidman, Johannes Backs

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Pepin, M. E., Konrad, P. J. M., Nazir, S., Bazgir, F., Maack, C., Nickel, A., Gorman, J. M., Hohl, M., Schreiter, F., Dewenter, M., de Britto Chaves Filho, A., Schulze, A., Karlstaedt, A., Frey, N., Seidman, C. E., Seidman, J. G., & Backs, J. (2025). Mitochondrial NNT Promotes Diastolic Dysfunction in Cardiometabolic HFpEF. Circulation Research. https://doi.org/10.1161/circresaha.125.326154

Vancouver

Pepin ME, Konrad PJM, Nazir S, Bazgir F, Maack C, Nickel A, et al. Mitochondrial NNT Promotes Diastolic Dysfunction in Cardiometabolic HFpEF. Circulation Research. 2025. doi:10.1161/circresaha.125.326154

BibTeX
@article{Pepin2025,
  author = {Pepin, Mark E and Konrad, Philipp J M and Nazir, Sumra and Bazgir, Farhad and Maack, Christoph and Nickel, Alexander and Gorman, Joshua M and Hohl, Mathias and Schreiter, Friederike and Dewenter, Matthias and de Britto Chaves Filho, Adriano and Schulze, Almut and Karlstaedt, Anja and Frey, Norbert and Seidman, Christine E and Seidman, Jonathan G and Backs, Johannes},
  title = {Mitochondrial NNT Promotes Diastolic Dysfunction in Cardiometabolic HFpEF},
  journal = {Circulation Research},
  year = {2025},
  doi = {10.1161/circresaha.125.326154}
}
Kostenlos starten →